Cartesian Therapeutics is a clinical-stage company developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is an mRNA CAR-T in Phase 2b ...

Phase 2b study will evaluate the safety, immunogenicity and efficacy of Vaxart’s next generation oral pill COVID-19 vaccine compared to an approved mRNA vaccine comparator — — The sentinel cohort is ...

Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery ...

The attempt on Hashim Safieddine was the latest in a series of aggressive Israeli attacks as it continues to try to dismantle ...

Authors Link RSAD2/Viperin Gene with Certain Chronically HIV-Infected Cells Paul M. Lieberman, Ph.D., and researchers at the Perelman School of Medicine's Center for AIDS Research and center director ...